Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial

This secondary analysis of a randomized clinical trial examines the risk of kidney or hepatic toxic effects among patients with impaired kidney function at baseline treated with remdesivir.

Detalles Bibliográficos
Autores principales: Cheng, Matthew, Fowler, Rob, Murthy, Srinivas, Pinto, Ruxandra, Sheehan, Nancy L., Tseng, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425145/
https://www.ncbi.nlm.nih.gov/pubmed/36036936
http://dx.doi.org/10.1001/jamanetworkopen.2022.29236
_version_ 1784778384581066752
author Cheng, Matthew
Fowler, Rob
Murthy, Srinivas
Pinto, Ruxandra
Sheehan, Nancy L.
Tseng, Alice
author_facet Cheng, Matthew
Fowler, Rob
Murthy, Srinivas
Pinto, Ruxandra
Sheehan, Nancy L.
Tseng, Alice
author_sort Cheng, Matthew
collection PubMed
description This secondary analysis of a randomized clinical trial examines the risk of kidney or hepatic toxic effects among patients with impaired kidney function at baseline treated with remdesivir.
format Online
Article
Text
id pubmed-9425145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-94251452022-09-16 Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial Cheng, Matthew Fowler, Rob Murthy, Srinivas Pinto, Ruxandra Sheehan, Nancy L. Tseng, Alice JAMA Netw Open Research Letter This secondary analysis of a randomized clinical trial examines the risk of kidney or hepatic toxic effects among patients with impaired kidney function at baseline treated with remdesivir. American Medical Association 2022-08-29 /pmc/articles/PMC9425145/ /pubmed/36036936 http://dx.doi.org/10.1001/jamanetworkopen.2022.29236 Text en Copyright 2022 Cheng M et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Cheng, Matthew
Fowler, Rob
Murthy, Srinivas
Pinto, Ruxandra
Sheehan, Nancy L.
Tseng, Alice
Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title_full Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title_fullStr Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title_full_unstemmed Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title_short Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial
title_sort remdesivir in patients with severe kidney dysfunction: a secondary analysis of the catco randomized trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425145/
https://www.ncbi.nlm.nih.gov/pubmed/36036936
http://dx.doi.org/10.1001/jamanetworkopen.2022.29236
work_keys_str_mv AT chengmatthew remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial
AT fowlerrob remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial
AT murthysrinivas remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial
AT pintoruxandra remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial
AT sheehannancyl remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial
AT tsengalice remdesivirinpatientswithseverekidneydysfunctionasecondaryanalysisofthecatcorandomizedtrial

Ejemplares similares